AUTL·Nasdaq·US
Autolus Therapeutics
Autolus Therapeutics is a commercial-stage biopharmaceutical company focused on developing, manufacturing, and selling programmed T-cell therapies. Its lead product, AUCATZYL, is an FDA-approved CAR-T therapy, and the company also advances a pipeline in hematological malignancies, solid tumors, and autoimmune diseases.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.
Recent Discoveries
Recent discoveries are part of the Pro plan.